Skip to main content
    O

    Oragenics Inc (OGEN)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • AMEX

    $0.21
    +0.01 (+6.06%)

    Market Cap: $893,370

    Last updated: Nov 17, 2026 at 4:27 PM ET

    Oragenics Inc (OGEN) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Oragenics (OGEN) has a market cap of $893,370. Its share count is up 189.06% from a year earlier. It holds $1.83M more cash than debt, 204.93% of its market cap.

    Total Valuation

    Market Cap$893,370
    Latest price (Nov 17, 2026)$0.21

    Key Dates

    The next earnings report is expected on Mar 15, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateMar 15, 2027 (expected)
    Last Earnings DateNov 12, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 1.88% in the quarter ended Sep 30, 2026 and grew 355.36% a year over 2 years.

    Shares Outstanding4.51M
    Shares Change (YoY)+189.06%
    Shares Change (QoQ)+1.88%
    Share Count Growth (2Y CAGR)+355.36%

    Price Statistics

    The stock is down 81.25% over 52 weeks and trades 51.16% below its 50-day average.

    Beta (1Y)1.27
    52-Week Change-81.25%
    1-Month Change-50.24%
    3-Month Change-60.39%
    6-Month Change-63.39%
    5-Year Change-99.97%
    10-Year Change-100.00%
    Total Return (1Y)-81.25%
    Total Return (3Y CAGR)-87.52%
    Total Return (5Y CAGR)-81.71%
    Max Drawdown (1Y)-82.16%
    Max Drawdown (3Y)-99.90%
    Sharpe Ratio (1Y)-1.91
    Correlation with SPY (1Y)0.20
    50-Day Average$0.43
    200-Day Average$0.57
    52-Week Range$0.17 to $1.11
    RSI (14 Days)18.3
    Average Volume (20 Days)2.61M

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 1.50x current liabilities, and total debt is 0.36x shareholder equity.

    Current Ratio1.50x
    Quick Ratio1.50x
    Debt / Equity0.36x
    Interest Coverage-550.98x

    Returns and Efficiency

    Return on invested capital is -656.14% and return on equity is -880.59% over the last 12 months.

    Return on Equity (ROE)-880.59%
    Return on Assets (ROA)-293.14%
    Return on Invested Capital (ROIC)-656.14%

    Scores

    OGEN has a Piotroski F-Score of 3 of 9, in the average band of 3 to 7.

    Piotroski F-Score3 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue of $0 over the last 12 months is down 100.00% from the 12 months before.

    Revenue$0
    Revenue Growth (YoY)-100.00%
    Operating Income-$9.94M
    Pretax Income-$9.85M
    Net Income-$9.62M

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 33.23% of the $3.28M in total assets.

    Cash and Equivalents$2.23M
    Total Debt$396.59K
    Net Cash$1.83M
    Net Cash Per Share$0.41
    Working Capital$1.09M
    Shareholder Equity$1.09M
    Book Value Per Share$0.24
    Total Assets$3.28M
    Total Liabilities$2.19M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    Operating Cash Flow-$9.26M
    FCF Per Share-$2.05

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Growth

    Book Value Per Share Growth (2Y CAGR)+25.89%
    Tangible Book Per Share Growth (2Y CAGR)+25.89%

    Revenue and profit by year

    Dividends and Yields

    OGEN does not pay a dividend.

    Buyback Yield-8.24%
    Shareholder Yield-8.24%

    Stock Splits

    The last split was a 1-for-30 reverse split on Jun 3, 2025.

    Last Split DateJun 3, 2025
    Split TypeReverse split
    Split Ratio1:30

    Peer Position

    Against 3 similar companies, OGEN has the lowest ROIC.

    ROIC-656.14% vs -187.86% median
    Revenue Growth (Trailing 4 Quarters, YoY)-100.00% vs -27.45% median

    Competitors compared

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About OGEN

    What is OGEN's market cap?

    Oragenics has a market cap of $893,370.

    How many shares of OGEN are outstanding?

    Oragenics has 4.51M shares outstanding. The count is up 189.06% from a year earlier.

    Does OGEN pay a dividend?

    No. Oragenics does not pay a dividend.

    How much debt does OGEN have?

    Oragenics has $396.59K of total debt and $2.23M of cash and equivalents, a net cash position of $1.83M.